Open access · OA
via OpenAlex
Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers
Maria Gabriela Valle Gottlieb, Ivana Beatrice Mânica da Cruz, Marta Maria Medeiros Frescura Duarte, Rafael Noal Moresco, Mário Wiehe, Carla Helena Augustin Schwanke, Luiz Carlos Bodanese
The Journal of Clinical Endocrinology & Metabolism · 2009 · ▲ 82 citations
Abstract
CONTEXT: Metabolic syndrome (MS) is described as a cluster of cardiometabolic risk factors. Studies suggest that ischemia-modified albumin (IMA) is a biomarker of cardiovascular diseases. IMA levels could be associated with cardiometabolic risks and represent a possible indication of microvascular dysfunction in MS patients. OBJECTIVE: To confirm this possible association, we evaluated the association between IMA levels and MS. DESIGN: We performed a case-control study (32 healthy individuals and 74 subjects with MS) to evaluate the association between MS, IMA, and other biomarkers [high-sensitivity C-reactive protein (hs-CRP), oxidized low-density lipoprotein (OxLDL), oxidized low-density lipoprotein autoantibodies (anti-OxLDL), IL-6, lipid profile, and glucose]. RESULTS: The MS group showed higher levels of IMA (0.618 +/- 0.1355) as well as higher levels of hs-CRP, OxLDL, anti-OxLDL, and IL-6 than did control subjects (IMA = 0.338 +/- 0.0486) (P < 0.01). Multivariate analysis showed that IMA and MS association was independent of sex, age, diabetes mellitus 2, and hypercholesterolemia. CONCLUSION: We found an association between IMA and MS. Additional studies including prospective genetic variation approaches need to be performed to help elucidate this association between IMA and MS and its potential clinical role.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1210/jc.2009-1592
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Gottlieb, M.G.V., Cruz, I.B.M.D., Duarte, M.M.M.F., Moresco, R.N., Wiehe, M., Schwanke, C.H.A., & Bodanese, L.C. (2009). Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers. <em>The Journal of Clinical Endocrinology & Metabolism</em>. https://doi.org/10.1210/jc.2009-1592
Vancouver
Gottlieb MGV, Cruz IBMD, Duarte MMMF, Moresco RN, Wiehe M, Schwanke CHA, et al. Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers. The Journal of Clinical Endocrinology & Metabolism. 2009. doi:10.1210/jc.2009-1592.
BibTeX
@article{maria2009Associ,
title = {Associations among Metabolic Syndrome, Ischemia, Inflammatory, Oxidatives, and Lipids Biomarkers},
author = {Maria Gabriela Valle Gottlieb and Ivana Beatrice Mânica da Cruz and Marta Maria Medeiros Frescura Duarte and Rafael Noal Moresco and Mário Wiehe and Carla Helena Augustin Schwanke and Luiz Carlos Bodanese},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2009},
doi = {10.1210/jc.2009-1592},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bioinformation 2026
Open access · CC-BY
CRP and IL-6 as cardiovascular risk markers in diabetes
Medical Sciences 2017
Open access · CC-BY
Inflammatory Biomarkers of Cardiometabolic Risk in Obese Egyptian Type 2 Diabetics
Canadian Medical Association Journal 2016
Open access · OA
Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality
Translational Pediatrics 2026
Open access · CC-BY
Inflammatory cytokines as biomarkers for disease severity in pediatric viral pneumonia: a systematic review and meta-analysis
Clinical Epigenetics 2018
Open access · CC-BY
Trajectories of inflammatory biomarkers over the eighth decade and their associations with immune cell profiles and epigenetic ageing
Journal of Translational Medicine 2019
Open access · CC-BY